You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Plasminogen

Showing 1 - 25 of 1,168
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ligneous Conjunctivitis Trial in Indianapolis, Florence, Padova (Human Plasminogen)

Completed
Has Results
  • Ligneous Conjunctivitis
  • Human Plasminogen
  • Indianapolis, Indiana
  • +2 more
Jan 2, 2023

Soluble Urokinase Plasminogen Activation Receptor to Rule Out

Not yet recruiting
  • Soluble Urokinase Plasminogen Activation Receptor
  • +3 more
  • Soluble Urokinase Plasminogen Activation Receptor measurement
  • Poitiers, France
    CHU of Poitiers
Jan 5, 2023

Hypoplasminogenemia Trial in Beverly Hills, Indianapolis, Nashville (Ryplazim)

No longer available
  • Hypoplasminogenemia
  • Ryplazim
  • Beverly Hills, California
  • +2 more
Dec 8, 2022

Plasminogen Deficiency Trial in Saskatoon (Aliquoted allogeneic donor plasma in patient's conjunctiva)

Not yet recruiting
  • Plasminogen Deficiency
  • Aliquoted allogeneic donor plasma in patient's conjunctiva
  • Saskatoon, Saskatchewan, Canada
    University of Saskatchewan
Nov 7, 2022

Ischemic Stroke, Acute Trial (Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA), Best Medical

Not yet recruiting
  • Ischemic Stroke, Acute
  • Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA)
  • Best Medical Management
  • (no location specified)
Nov 24, 2022

Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown Trial in Liverpool (Alteplase)

Recruiting
  • Acute Respiratory Failure
  • +2 more
  • Liverpool, New South Wales, Australia
    Intensive Care Unit, Liverpool Hospital, South Western Sydney Lo
Sep 15, 2022

Menstrual Bleeding, Heavy Trial in Portland (Sample Collection and Endometrial Biopsy)

Not yet recruiting
  • Menstrual Bleeding, Heavy
  • Sample Collection and Endometrial Biopsy
  • Portland, Oregon
    OHSU
May 8, 2023

Pleural Infection Trial in Hong Kong (Tissue Plasminogen Activator)

Not yet recruiting
  • Pleural Infection
  • Tissue Plasminogen Activator
  • Hong Kong, Hong Kong
  • +1 more
Mar 10, 2023

Hematoma, Subdural, Fibrinolytic; Hemorrhage Trial in Hamilton (Tissue Plasminogen Activator, Placebo)

Not yet recruiting
  • Hematoma, Subdural
  • Fibrinolytic; Hemorrhage
  • Tissue Plasminogen Activator
  • Placebo
  • Hamilton, Ontario, Canada
    Hamilton General Hospital
Aug 4, 2022

Ocular Trauma Trial in Hangzhou (Tissue Plasminogen Activator)

Recruiting
  • Ocular Trauma
  • Tissue Plasminogen Activator
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Feb 20, 2023

Acute Stroke Trial in Izmir (theory training, theory and simulation training)

Completed
  • Acute Stroke
  • theory training
  • theory and simulation training
  • İzmir, Turkey
    Ozge Soydaner
Jul 15, 2022

Covid19 Trial in Chicago (TM5614, Placebo)

Suspended
  • Covid19
  • Chicago, Illinois
    Northwestern University
Feb 14, 2022

Melanoma Trial (Tranexamic acid, Saline)

Not yet recruiting
  • Melanoma
  • (no location specified)
Jun 2, 2023

Acute Ischemic Stroke Trial (IV tPA (Activase))

Not yet recruiting
  • Acute Ischemic Stroke
  • IV tPA (Activase)
  • (no location specified)
Feb 24, 2022

Ligneous Conjunctivitis Trial (Plasminogen)

Available
  • Ligneous Conjunctivitis
  • Plasminogen
  • (no location specified)
May 24, 2022

Recombinant Tissue Plasminogen Activator Treated Chinese Acute

Completed
  • Stroke
  • Shanghai, China
    Boehringer Ingelheim (China) Investment Co., ltd.
Dec 22, 2022

Alteplase in Elderly Acute Ischemic Stroke Patients During

Active, not recruiting
  • Stroke
  • Shanghai, China
    Boehringer Ingelheim (China) Investment Co., ltd.
Jan 9, 2023

Ligneous Conjunctivitis, Left Eye Trial in St. John's (Allogenic plasma aliquots, a source of plasminogen)

Enrolling by invitation
  • Ligneous Conjunctivitis, Left Eye
  • Allogenic plasma aliquots, a source of plasminogen
  • St. John's, Newfoundland and Labrador, Canada
    Memorial University of Newfoundland
Apr 5, 2022

Stroke, Acute Ischemic Trial (Tissue Plasminogen Activator (Alteplase))

Not yet recruiting
  • Stroke, Acute Ischemic
  • Tissue Plasminogen Activator (Alteplase)
  • (no location specified)
Aug 16, 2022

Pleural Infection Trial (Intrapleural fibrinolytic with alteplase 5mg and pulmozyme 5 mg, Saline irrigation with 250 mls normal

Not yet recruiting
  • Pleural Infection
  • Intrapleural fibrinolytic with alteplase 5mg and pulmozyme 5 mg
  • Saline irrigation with 250 mls normal saline (over 1 hour)
  • (no location specified)
Jun 19, 2023

Hyperfibrinolysis During Vaginal Delivery and Cesarean Section

Recruiting
  • Hyperfibrinolysis
  • +3 more
  • Coagulation tests (TEG, Levels of F1, F2, hs-D-dimer, Plasminogen, PAI 1+2), SpHb before discharge
  • Graz, Styria, Austria
    Medical University of Graz
Jul 26, 2023

Periodontal Diseases, Periodontal Attachment Loss, Periodontal Disease, AVDC Stage 3 Trial in Istanbul (low level laser therapy,

Completed
  • Periodontal Diseases
  • +4 more
  • low level laser therapy
  • non-surgical periodontal treatment
  • Istanbul, Turkey
    Beykent University
Jan 31, 2022

Hypoplasminogenemia, Congenital Plasminogen Deficiency Trial in Indianapolis, Oslo (Plasminogen (Human) intravenous)

Completed
Has Results
  • Hypoplasminogenemia
  • Congenital Plasminogen Deficiency
  • Plasminogen (Human) intravenous
  • Indianapolis, Indiana
  • +1 more
Jul 30, 2021

SuPAR in Adult Patients With Covid-19

Completed
  • Covid19
  • Soluble Urokinase Plasminogen Activator Receptor
  • Larissa, Thessaly, Greece
    University Hospital of Larisa, Department of Anesthesiology
Oct 16, 2021

Acute Ischemic Stroke Trial (rhTNK-tPA, Antiplatelet Agents)

Not yet recruiting
  • Acute Ischemic Stroke
  • (no location specified)
Mar 1, 2023